Companies › Treeline Biosciences
4 active drug programs in 10 registered trials: 7 Phase 1, 3 Phase 2; Oncology; next expected readout Nov 2026.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| zeprumetostat (TLN-254) EZH2 inhibitor | KMT2D | Phase 1 | Lymphoma; Peripheral T Cells Lymphoma (PTCL); Bladder Urothelial Carcinoma; Follicular Lymphoma … | Nov 2026 |
| TLN-499 BCL-2 family protein inhibitor | – | Phase 1 | Small Cell Lung Cancer ( SCLC ) | Aug 2030 |
| TLN-121 | – | Phase 1 | Lymphoma | Sep 2030 |
| TLN-372 KRAS inhibitor | – | Phase 1 | KRAS Mutant Solid Tumors | Dec 2031 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT06733441 | zeprumetostat (TLN-254) | Phase 1 | Lymphoma | Oncology | Nov 2026 |
| NCT07502768 | zeprumetostat (TLN-254) | Phase 1 | Extranodal NK/T-cell Lymphoma | Oncology | Dec 2027 |
| NCT07692529 | zeprumetostat (TLN-254) | Phase 1 | Large Granular Lymphocyte Leukemia | Oncology | Dec 2027 |
| NCT07372352 | zeprumetostat (TLN-254) | Phase 2 | Peripheral T Cells Lymphoma (PTCL) | Oncology | Jan 2028 |
| NCT07717242 | zeprumetostat (TLN-254) | Phase 2 | Bladder Urothelial Carcinoma | Oncology | Jun 2028 |
| NCT07555470 | zeprumetostat (TLN-254) | Phase 2 | Follicular Lymphoma | Oncology | Dec 2029 |
| NCT07713732 | TLN-499 | Phase 1 | Small Cell Lung Cancer ( SCLC ) | Oncology | Aug 2030 |
| NCT07082803 | TLN-121 | Phase 1 | Lymphoma | Oncology | Sep 2030 |
| NCT07082803 | zeprumetostat (TLN-254) | Phase 1 | Lymphoma | Oncology | Sep 2030 |
| NCT07204340 | TLN-372 | Phase 1 | KRAS Mutant Solid Tumors | Oncology | Dec 2031 |
–
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.